Asked by: Lorraine Beavers (Labour - Blackpool North and Fleetwood)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of integrating all at risk screening for breast cancer into the National NHS Breast Screening Programme.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The new and world-leading NHS National Inherited Cancer Predisposition Registry (NICPR), part of the National Disease Registration Service, will help the National Health Service to deliver proactive, targeted prevention, surveillance, and earlier diagnosis for people and their families. Women at Very High Risk (VHR) of breast cancer are now identified within the NICPR and referred into the NHS Breast Screening Programme (NHSBSP), which has enabled reconciliation to ensure that all identified women are safely referred into the programme. This is a step towards a fully electronic referral VHR process into the NHSBSP.
The Government is advised on all screening matters by the UK National Screening Committee (UK NSC), an independent scientific advisory committee which is made up of leading medical and screening experts. Where the UK NSC is confident that offering screening provides more good than harm, they recommend a screening programme.
In 2022 the remit of the UK NSC was expanded to include targeted, and risk stratified screening, in addition to population screening. So far, the UK NSC has not made a recommendation for targeted screening of women at a moderate or high risk of breast cancer.
Currently, if women reach the criteria for moderate or high- risk screening with surveillance recommended, this is offered as part of screening provision managed locally with NHS trusts.
Asked by: Andrew Snowden (Conservative - Fylde)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how funding for undercover online policing units will be distributed; and what outcomes each unit is expected to deliver.
Answered by Sarah Jones - Minister of State (Home Office)
Undercover Online Police Officers (UCOLs) deploy online to identify and pursue offenders seeking to sexually exploit children. Using unique capabilities and covert tactics to target dangerous offenders, UCOLs focus on a range of offences including grooming, peer-to-peer offending, live streaming, contact offences and historic or current familial offending.
The UCOL Network has achieved continued success, surpassing its targeted annual outcomes for operational activity and responding to emerging threats, including the proliferation of AI-generated child sexual abuse material.
Given the UCOLs’ continued success in disrupting online child sexual abuse, the Home Office has invested £11.7m in this capability this past FY 2025/26. The government has also committed to expand the use of the Home Office’s network of Undercover Online Operatives to address Violence Against Women and Girls in its’ “Freedom from Violence and Abuse: a cross-government strategy to build a safer society for women and girls”, published on 18th December 2025.
Asked by: Fleur Anderson (Labour - Putney)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his department is taking to expand the roll out surveillance programmes to (a) identify people at highest risk of pancreatic cancer and (b) support earlier diagnosis.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Earlier diagnosis of cancers, including pancreatic cancer, is a priority for the Government. NHS England is working on case-finding approaches for less survivable cancers, where the evidence suggests this is appropriate. This includes a public-facing Family History Checker, which enables people, and their families, affected by pancreatic cancer to self-assess if they may inherit risk. Individuals identified as being at risk are referred directly to the European Registry of Hereditary Pancreatic Diseases research trial, which aims to understand inherited conditions of the pancreas. Referrals to the trial can be made by any healthcare professional across all health sectors or by individuals via self-referral, contributing to a centralised approach to case-finding.
The National Disease Registration Service has developed the National Inherited Cancer Predisposition Register (NICPR), which launched on 30 June. The NICPR looks at a wide range of cancers for which there is an increased inherited risk, including for less survivable cancers. It aims to identify high-risk individuals who are eligible for targeted screening and surveillance and will act as an electronic referral route into national screening programmes, where these exist.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the (a) development and (b) rollout of biomarker tests to support early detection of (i) pancreatic cancer and (ii) other less survivable cancers in primary care services.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
million NHS programme. This is funding more than 300 general practices (GPs) to identify pancreatic cancer early by screening high-risk patients over 60 years old with new diabetes diagnoses and unexplained weight loss. More than 80 GPs across England have begun using the initiative. It will be extended to the other general practices participating in the trial by the end of the year.
The National Disease Registration Service (NDRS) is developing a National Inherited Cancer Predisposition Register (NICPR), which launched on 30 June. The NICPR looks at a wide range of cancers for which there is an increased inherited risk, including for less survivable cancers. It aims to identify high-risk individuals who are eligible for targeted screening and surveillance, and will act as an electronic referral route into national screening programmes where these exist.
Asked by: Daniel Zeichner (Labour - Cambridge)
Question to the Department for Business and Trade:
To ask the Secretary of State for Business and Trade, what steps he is taking to ensure that UK technology companies working with Israeli companies in the (a) defence and (b) surveillance sectors comply with UK (i) human rights and (ii) export control policies.
Answered by Chris Bryant - Minister of State (Department for Business and Trade)
Where an item, including technology, is specified in the UK’s Strategic Export Control list, its export or transfer by electronic means is subject to export control. Exporters of such items must seek an export licence from the Export Control Joint Unit (ECJU), who assess applications against the Strategic Export Licensing Criteria.
These criteria include ‘respect for human rights and fundamental freedoms’, and consideration of where there is a clear risk an export may be used to commit or facilitate internal repression, or a serious breach of international humanitarian law.
All licences are kept under careful and continual review as standard. We are able to suspend, refuse or revoke licences as circumstances require.
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of a national multi-cancer case finding programme to identify individuals at high risk of (a) pancreatic cancer and (b) all other cancers.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is developing case-finding approaches for less survivable cancers where the evidence supports this, including pancreatic cancer.
This work includes the development of a public-facing Family History Checker in partnership with Pancreatic Cancer UK, which enables individuals and families affected by pancreatic cancer to assess inherited risk. Those identified as being at risk are referred directly to the European Registry of Hereditary Pancreatic Diseases research trial. Referrals can be made by any healthcare professional or by individuals via self-referral, contributing to a more consistent and centralised approach to case-finding.
The National Disease Registration Service has launched the National Inherited Cancer Predisposition Register, which identifies individuals at increased inherited risk of a wide range of cancers, including pancreatic cancer. The register supports targeted screening and surveillance and will act as an electronic referral route into national screening programmes where these exist.
Asked by: Patrick Hurley (Labour - Southport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of establishing a national multi-cancer case-finding initiative to identify people at higher risk of (a) pancreatic and (b) other less survivable cancers.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England is working on case-finding approaches for less survivable cancers, where the evidence suggests this is appropriate. This includes a public-facing Family History Checker, which enables people and their families affected by pancreatic cancer to self-assess if they may inherit risk. Individuals identified as being at risk are referred directly to the European Registry of Hereditary Pancreatic Diseases research trial, which aims to understand inherited conditions of the pancreas. Referrals to the trial can be made by any healthcare professional across all health sectors or by individuals via self-referral, contributing to a centralised approach to case-finding.
The National Disease Registration Service is developing a National Inherited Cancer Predisposition Register (NICPR), which launched on 30 June. The NICPR looks at a wide range of cancers for which there is an increased inherited risk, including for less survivable cancers. It aims to identify high-risk individuals who are eligible for targeted screening and surveillance and will act as an electronic referral route into national screening programmes where these exist.
Asked by: David Davis (Conservative - Goole and Pocklington)
Question to the Home Office:
To ask the Secretary of State for the Home Department, if her Department will withdraw outstanding Technical Capability Notices relating to encryption.
Answered by Dan Jarvis - Minister of State (Cabinet Office)
For reasons of national security, it has been a long-standing position that the Government does not confirm or deny Technical Capability Notices under the Investigatory Powers Act 2016.
Asked by: Angus MacDonald (Liberal Democrat - Inverness, Skye and West Ross-shire)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what assessment she has made of the potential role of data surveillance in welfare policy.
Answered by Andrew Western - Parliamentary Under-Secretary (Department for Work and Pensions)
No assessment has been made as the DWP does not currently or have any plans to use data surveillance to regulate, police or monitor the actions of individuals or groups in receipt of benefits.
Asked by: James Cartlidge (Conservative - South Suffolk)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, how many orders of electronic surveillance equipment his Department has made for use by the armed forces since 5 July 2024.
Answered by Maria Eagle
The Department procure a number of systems across all domains, many of which are integrated into larger platforms. Consequently, the information requested is not held centrally and could only be provided at disproportionate cost.